|
Von der Hompage From the Chairman AN OPEN LETTER TO ALL SHAREHOLDERS AND THE GENERAL PUBLIC Nobody benefits when rumors dictate the movement of stock or the direction of a company. While it is true that most stocks trade on “future hope” and some hype, it is also true that the personality of a real company should be based upon fact, calculated predictions and honesty. It is often said that life is shaped by events… and to a great degree I believe that there is truth to that adage. Med Gen is now seven years old. Most companies don’t make it past the three-year mark. So you must believe that we have great products, great management or both. We certainly never had the benefit of a lot of money. The biggest single event that is now shaping our destiny is the lawsuit that has been recently announced in a News Release by the company and which has been discussed ad nauseum in almost every chat room on the Internet. Let me clarify for all, the future events that are apt to take place and the possible effects on our company. Mind you, the attitude of management is “business as usual”. You have been made aware of significant progress in marketing, distribution and R&D efforts to bring out new and exciting products. This massive effort on the part of management will no doubt make Med Gen an exciting and highly prosperous company. Yet we must get over the legal problems in order to build immediate shareholder loyalty and long-term investors. With regard to the lawsuit, there are several events going on at the same time. There is a (i) “motion for a new trial”, (ii) negotiation for settlement, (iii) Appeal for a new trial on damage award and (iv) filing prepared for protection under the chapter 11 bankruptcy code. None of these events, other than a negotiated settlement, would happen before March 2005 and maybe, in the case of an Appeal until early 2006. The company’s legal team will protect us all during the process, leaving management free to run the company [not that I don’t worry a lot- and oversee the process]. The point is, to make a “buy” or “no buy” decision at this point purely on the speculative outcome of the legal action does not make much sense. As the gurus say, buy low sell high. If you as an investor feel that our stock at this level is undervalued, this could well be the buying opportunity of a lifetime. Disclaimers aside, Snorenz® and Good Night’s Sleep® are products of unparallel value with huge market potential. Did you know that the combined domestic markets for these products exceed $1.6 billion? You should also know that Good Night’s Sleep is unique in that it has no competition as a liquid spray sleep-aid…Snorenz® has only one competitor and Snorenz® is the only all natural snore-relief brand, an original patented formula that has been proven over 7 years and major studies to do what it says it will do. We are a company with real products, sold in major stores throughout the USA and soon in major markets World-Wide. Need I say more! |
|
| aus der Diskussion: | +++ 350 % MÖGLICH IN SEHR KURZER +++ |
| Autor (Datum des Eintrages): | UH1d (13.10.04 13:39:54) |
| Beitrag: | 47 von 56 (ID:14656478) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |